The FDA has issued a warning letter to BMC Medical concerning unapproved modifications to APAP devices and a failure to report a firmware correction for unexpected shutdowns. This is a critical alert for manufacturers and developers in the medical device industry, highlighting the stringent regulatory requirements for device modifications and reporting. Non-compliance can lead to significant legal and operational consequences, emphasizing the need for robust compliance processes.
Read the full article at Sleep Review
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.





